Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Lilly prepares compounds for controlling TxA2

Jan. 23, 1998

Boehringer Ingelheim develops new antiplatelet agents

Jan. 21, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Jan. 16, 1998

Oral heparin preparation completes additional phase I trials

Jan. 16, 1998

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

Jan. 13, 1998

Roberts seeks to broaden market for Agrylin

Jan. 13, 1998

Cell adhesion inhibitors from Merck KGaA

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...